These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9155555)

  • 1. Survival and treatment of AIDS patients 1984-1993: experience of a smaller east London HIV centre.
    Hillman RJ; Beck EJ; Mandalia S; Satterthwaite H; Rogers PA; Forster GE; Goh BT
    Genitourin Med; 1997 Feb; 73(1):44-8. PubMed ID: 9155555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic.
    Easterbrook PJ; Yu LM; Goetghebeur E; Boag F; McLean K; Gazzard B
    AIDS; 2000 Mar; 14(5):561-71. PubMed ID: 10780719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.
    Graham NM; Zeger SL; Park LP; Phair JP; Detels R; Vermund SH; Ho M; Saah AJ
    Lancet; 1991 Aug; 338(8762):265-9. PubMed ID: 1677108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of morbidity and mortality in AIDS patients on Pneumocystis carinii prophylaxis who died during hospital admission: a report of 50 diseased patients.
    Hentzen BT; Schreij G
    Neth J Med; 1996 Sep; 49(3):101-5. PubMed ID: 8854672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of CD4 lymphocyte count to predict long-term survival free of AIDS after HIV infection.
    Phillips AN; Sabin CA; Elford J; Bofill M; Janossy G; Lee CA
    BMJ; 1994 Jul; 309(6950):309-13. PubMed ID: 7916226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993.
    Osmond D; Charlebois E; Lang W; Shiboski S; Moss A
    JAMA; 1994 Apr; 271(14):1083-7. PubMed ID: 7908703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of zidovudine treatment and the pneumocystis carinii prophylaxis in natural history of patients with HIV infection].
    Sáiz Hervas E; Castilla Castellano V; Miquel Plaza J; Benito Blanco AM; Martín Llorens MM; Pastor de Blas M; Izquierdo P; Muñoz Jareño MA; Sierra A; Nieto MA; Moreno Collado AM; Fraguas C
    An Med Interna; 1998 Mar; 15(3):132-7. PubMed ID: 9580410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
    Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
    Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
    Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS in Africans living in London.
    O'Farrell N; Lau R; Yoganathan K; Bradbeer CS; Griffin GE; Pozniak AL
    Genitourin Med; 1995 Dec; 71(6):358-62. PubMed ID: 8566973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.
    Easterbrook PJ; Keruly JC; Creagh-Kirk T; Richman DD; Chaisson RE; Moore RD
    JAMA; 1991 Nov; 266(19):2713-8. PubMed ID: 1942423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease progression and survival in HIV-1-infected Africans in London.
    Del Amo J; Petruckevitch A; Phillips A; Johnson AM; Stephenson J; Desmond N; Hanscheid T; Low N; Newell A; Obasi A; Paine K; Pym A; Theodore CM; De Cock KM
    AIDS; 1998 Jul; 12(10):1203-9. PubMed ID: 9677170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between primary source of ambulatory care and access to and outcomes of treatment among AIDS patients.
    McLaughlin TJ; Soumerai SB; Weinrib D; Aupont O; Cotton D
    Int J Qual Health Care; 1999 Aug; 11(4):293-300. PubMed ID: 10501599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital service interventions and improving survival of AIDS patients St Mary's Hospital, London, 1982-1991.
    Beck EJ; Mandalia S; Miller DL; Harris JR
    Int J STD AIDS; 1998 May; 9(5):280-90. PubMed ID: 9639206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects on survival of early treatment of human immunodeficiency virus infection.
    Graham NM; Zeger SL; Park LP; Vermund SH; Detels R; Rinaldo CR; Phair JP
    N Engl J Med; 1992 Apr; 326(16):1037-42. PubMed ID: 1347907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 x 106 /l.
    Koletar SL; Heald AE; Finkelstein D; Hafner R; Currier JS; McCutchan JA; Vallee M; Torriani FJ; Powderly WG; Fass RJ; Murphy RL;
    AIDS; 2001 Aug; 15(12):1509-15. PubMed ID: 11504983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ lymphocyte response to zidovudine as a predictor of AIDS-free time and survival time.
    Graham NM; Piantadosi S; Park LP; Phair JP; Rinaldo CR; Fahey JL
    J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1258-66. PubMed ID: 7901384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
    Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
    JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral treatment and progression to AIDS in HIV seroconverters from different risk groups. HIV Italian Seroconversion Study.
    Dorrucci M; Pezzotti P; Phillips AN; Alliegro MB; Rezza G
    AIDS; 1997 Mar; 11(4):461-7. PubMed ID: 9084793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.